Mesoblast received a key patent from the United States Patent and Trademark Office for the proprietary Mesenchymal Precursor Cell technology for treating patients with degenerated intervertebral discs.
↧
Mesoblast received a key patent from the United States Patent and Trademark Office for the proprietary Mesenchymal Precursor Cell technology for treating patients with degenerated intervertebral discs.